AstraZeneca signs $1.35B Alteogen deal for subcutaneous cancer drugs – FiercePharma

20th March 2025

AstraZeneca signs $1.35B Alteogen deal for subcutaneous cancer drugs FiercePharma

OPUS IP on X (formerly Twitter)…

Twitter feed is not available at the moment.

RECENT PATENT NEWS…

Guardant didn’t demonstrate two prior patent applications and two research papers rendered the patent obvious, according to the decision - Bloomberg Law News
St. Petersburg bars migrant workers with ‘labor patents’ from jobs in stores, salons, and gyms. Citizens of Belarus, Kazakhstan, Armenia and Kyrgyzstan are exempt. - Meduza
AyrKing Receives U.S. Patent for Space-Saving Breading and Sifting Station - Business Wire
AI, Inventorship, and Authorship: What Patent and Copyright Owners Need to Know - JD Supra

UK BUSINESS NEWS…

'I'd spend $1,000 on a wedding present'
'I'd spend $1,000 on a wedding present'
'I paid thousands to a company for jobs that never came'
Banks say Healey is planning Budget tax raid on their profits

Designed by Industrial Action

Copyright © 2026 OPUS IP Limited. All Rights Reserved

OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION